Literature DB >> 9916114

Role of lipopolysaccharide sialylation in serum resistance of serogroup B and C meningococcal disease isolates.

U Vogel1, H Claus, G Heinze, M Frosch.   

Abstract

alpha-2,3-Sialyltransferase mutants of three genetically and phenotypically diverse Neisseria meningitidis strains were compared with regard to resistance to human serum and systemic spread in the infant rat. Lipopolysaccharide sialylation was found to be of minor importance for the resistance of serogroup B and C meningococcal disease isolates to complement attack.

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 9916114      PMCID： PMC96410     

Source DB:  PubMed          Journal:  Infect Immun        ISSN： 0019-9567            Impact factor:   3.441


  28 in total

1.  Gonococcal lipooligosaccharide sialylation prevents complement-dependent killing by immune sera.

Authors:  L M Wetzler; K Barry; M S Blake; E C Gotschlich
Journal:  Infect Immun       Date:  1992-01       Impact factor: 3.441

2.  Sialic acid of group B Neisseria meningitidis regulates alternative complement pathway activation.

Authors:  G A Jarvis; N A Vedros
Journal:  Infect Immun       Date:  1987-01       Impact factor: 3.441

3.  Influence of nutrient limitation and low pH on serogroup B Neisseria meningitidis capsular polysaccharide levels: correlation with virulence for mice.

Authors:  L Masson; B E Holbein
Journal:  Infect Immun       Date:  1985-02       Impact factor: 3.441

4.  Sialylation of lipopolysaccharide and loss of absorption of bactericidal antibody during conversion of gonococci to serum resistance by cytidine 5'-monophospho-N-acetyl neuraminic acid.

Authors:  N J Parsons; J R Andrade; P V Patel; J A Cole; H Smith
Journal:  Microb Pathog       Date:  1989-07       Impact factor: 3.738

5.  Endogenous sialylation of the lipooligosaccharides of Neisseria meningitidis.

Authors:  R E Mandrell; J J Kim; C M John; B W Gibson; J V Sugai; M A Apicella; J M Griffiss; R Yamasaki
Journal:  J Bacteriol       Date:  1991-05       Impact factor: 3.490

Review 6.  Complement deficiency states and infection: epidemiology, pathogenesis and consequences of neisserial and other infections in an immune deficiency.

Authors:  S C Ross; P Densen
Journal:  Medicine (Baltimore)       Date:  1984-09       Impact factor: 1.889

7.  Cytidine 5'-monophospho-N-acetylneuraminic acid or a related compound is the low Mr factor from human red blood cells which induces gonococcal resistance to killing by human serum.

Authors:  C A Nairn; J A Cole; P V Patel; N J Parsons; J E Fox; H Smith
Journal:  J Gen Microbiol       Date:  1988-12

8.  Molecular characterization and expression in Escherichia coli of the gene complex encoding the polysaccharide capsule of Neisseria meningitidis group B.

Authors:  M Frosch; C Weisgerber; T F Meyer
Journal:  Proc Natl Acad Sci U S A       Date:  1989-03       Impact factor: 11.205

9.  Antibodies to N-terminal peptides of gonococcal porin are bactericidal when gonococcal lipopolysaccharide is not sialylated.

Authors:  C Elkins; N H Carbonetti; V A Varela; D Stirewalt; D G Klapper; P F Sparling
Journal:  Mol Microbiol       Date:  1992-09       Impact factor: 3.501

10.  Lipooligosaccharides (LOS) of Neisseria gonorrhoeae and Neisseria meningitidis have components that are immunochemically similar to precursors of human blood group antigens. Carbohydrate sequence specificity of the mouse monoclonal antibodies that recognize crossreacting antigens on LOS and human erythrocytes.

Authors:  R E Mandrell; J M Griffiss; B A Macher
Journal:  J Exp Med       Date:  1988-07-01       Impact factor: 14.307
View more
  28 in total

1.  An evaluation of the role of properdin in alternative pathway activation on Neisseria meningitidis and Neisseria gonorrhoeae.

Authors:  Sarika Agarwal; Viviana P Ferreira; Claudio Cortes; Michael K Pangburn; Peter A Rice; Sanjay Ram
Journal:  J Immunol       Date:  2010-06-07       Impact factor: 5.422

2.  Bacteremia in an immunocompromised patient caused by a commensal Neisseria meningitidis strain harboring the capsule null locus (cnl).

Authors:  Ulrich Vogel; Heike Claus; Lutz von Müller; Donald Bunjes; Johannes Elias; Matthias Frosch
Journal:  J Clin Microbiol       Date:  2004-07       Impact factor: 5.948

3.  Inhibition of the alternative pathway of nonhuman infant complement by porin B2 contributes to virulence of Neisseria meningitidis in the infant rat model.

Authors:  Lisa A Lewis; David M Vu; Dan M Granoff; Sanjay Ram
Journal:  Infect Immun       Date:  2014-03-31       Impact factor: 3.441

4.  Enhanced factor H binding to sialylated Gonococci is restricted to the sialylated lacto-N-neotetraose lipooligosaccharide species: implications for serum resistance and evidence for a bifunctional lipooligosaccharide sialyltransferase in Gonococci.

Authors:  Sunita Gulati; Andrew Cox; Lisa A Lewis; Frank St Michael; Jianjun Li; Ryan Boden; Sanjay Ram; Peter A Rice
Journal:  Infect Immun       Date:  2005-11       Impact factor: 3.441

5.  The meningococcal vaccine candidate GNA1870 binds the complement regulatory protein factor H and enhances serum resistance.

Authors:  Guillermo Madico; Jo Anne Welsch; Lisa A Lewis; Anne McNaughton; David H Perlman; Catherine E Costello; Jutamas Ngampasutadol; Ulrich Vogel; Dan M Granoff; Sanjay Ram
Journal:  J Immunol       Date:  2006-07-01       Impact factor: 5.422

6.  Differential expression and transcriptional analysis of the alpha-2,3-sialyltransferase gene in pathogenic Neisseria spp.

Authors:  Mathanraj Packiam; Dawn M Shell; Shi V Liu; Yao-Bin Liu; David J McGee; Ranjana Srivastava; Samar Seal; Richard F Rest
Journal:  Infect Immun       Date:  2006-05       Impact factor: 3.441

7.  Functional comparison of the binding of factor H short consensus repeat 6 (SCR 6) to factor H binding protein from Neisseria meningitidis and the binding of factor H SCR 18 to 20 to Neisseria gonorrhoeae porin.

Authors:  Jutamas Shaughnessy; Lisa A Lewis; Hanna Jarva; Sanjay Ram
Journal:  Infect Immun       Date:  2009-03-09       Impact factor: 3.441

8.  Structure of the LPS O-chain from Fusobacterium nucleatum strain 10953, containing sialic acid.

Authors:  Evgeny Vinogradov; Frank St Michael; Kiyonobu Homma; Ashu Sharma; Andrew D Cox
Journal:  Carbohydr Res       Date:  2017-01-28       Impact factor: 2.104

9.  Acquisition of factor H by a novel surface protein on group B Streptococcus promotes complement degradation.

Authors:  Ravi Maruvada; Nemani V Prasadarao; C E Rubens
Journal:  FASEB J       Date:  2009-07-16       Impact factor: 5.191

10.  Defining targets for complement components C4b and C3b on the pathogenic neisseriae.

Authors:  Lisa A Lewis; Sanjay Ram; Alpana Prasad; Sunita Gulati; Silke Getzlaff; Anna M Blom; Ulrich Vogel; Peter A Rice
Journal:  Infect Immun       Date:  2007-11-05       Impact factor: 3.441
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.